Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Ab&B Bio-Tech CO., LTD. JS Class H ( (HK:2627) ).
Ab&B Bio-Tech has nominated seasoned finance professional Ms. Lui Mei Ka as an independent non-executive director for its second board session, with her appointment also including a role on the audit committee, subject to shareholder approval and related amendments to the company’s articles of association. The move follows the pending departure of non-executive director and audit committee member Mr. Cheng Qianwen, and is expected to strengthen the company’s corporate governance with Ms. Lui’s extensive background in financial management, listed company oversight, and compliance across multiple Hong Kong-listed firms.
More about Ab&B Bio-Tech CO., LTD. JS Class H
Ab&B Bio-Tech CO., LTD. JS is a biotechnology company based in the People’s Republic of China, listed on the Hong Kong Stock Exchange. The group focuses on biopharmaceutical research and related technologies, positioning itself within the broader life sciences and healthcare sector and serving both domestic and international markets.
Average Trading Volume: 793,219
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$11.54B
Learn more about 2627 stock on TipRanks’ Stock Analysis page.